Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era

Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era

Objective/Background: Relapse is the most common cause of treatment failure after allogeneic hematopoietic cell transplantation (alloHCT). No standard of care exists, and a wide range of treatments are used for post-alloHCT relapse. In the recent era, several novel therapies including targeted agent...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sanghee Hong, Lisa Rybicki, Donna Corrigan, Betty K. Hamilton, Ronald Sobecks, Matt Kalaycio, Aaron T. Gerds, Rob M. Dean, Brian T. Hill, Brad Pohlman, Deepa Jagadeesh, Faiz Anwer, Navneet S. Majhail
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Allogeneic stem cell transplantation
Post-transplant relapse
Relapse
Survival
Diseases of the blood and blood-forming organs
RC633-647.5
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/7a57caab7c1048adaf808b1df5de420c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/7a57caab7c1048adaf808b1df5de420c

Ejemplares similares